Hossny Alaws
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hossny Alaws has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Augustine S. Lee
Pulmonary Medicine, Mayo Clinic, Jacksonville, Florida, USA
1 shared publication - Danielle H. W. Vlecken
SV Biotech BV, Robert Boyleweg 4, 2333 CG Leiden, The Netherlands
1 shared publication - Hassan Baig
Division of Pulmonary, Allergy, Sleep and Respiratory Medicine, Mayo Clinic
1 shared publication - Mohamed I. Ibrahim
Division of Pulmonary Medicine, Department of Medicine, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL 32224, USA
1 shared publication - Scott A. Helgeson
Digital Engineering & Artificial Intelligence Laboratory (DEAL), Mayo Clinic, Jacksonville, FL 32224, USA
1 shared publication
Latest Publications
- Open Access
- 26 April 2026
- Published by MDPI AG in Journal of Xenobiotics
- Vol. 16 (3) , 72
The Association of Microplastics in Peripheral Blood and Pulmonary Disease: A Pilot Study
Microplastics may pose health risks, particularly for chronic lung diseases. Clarifying the link between circulating microplastics and pulmonary disease is vital for shaping research and interventions. The objective of this study was to evaluate whether microplastics in peripheral blood are associated with COPD or IPF vs. no lung disease. In this pilot prospective case-control study, participants were grouped as control (n = 10), COPD (n = 9), or IPF (n = 10). Relevant comorbidities and exposures were obtained from records and questionnaires. All underwent standardized blood collection (PlasticTox©). Samples were analyzed for total microplastic concentration, stratified by size (p < 0.01). Particle burdens p < 0.01). After adjusting for smoking, only the <10 µm fraction remained independently associated with lung disease (adjusted odds ratio 1.94 (95% CI, 1.23–7.04)). In this pilot exploratory study, individuals with COPD or IPF showed greater circulating microplastic levels than controls. These findings should be interpreted as hypothesis-generating, and larger analytically validated studies are needed to clarify directionality, causal mechanisms, contamination control, and the clinical relevance of circulating microplastic burden.
- 26 April 2026
- Published by MDPI AG in Journal of Xenobiotics
- Vol. 16 (3) , 72
Open AccessThe Association of Microplastics in Peripheral Blood and Pulmonary Disease: A Pilot Study
Microplastics may pose health risks, particularly for chronic lung diseases. Clarifying the link between circulating microplastics and pulmonary disease is vital for shaping research and interventions. The objective of this study was to evaluate whether microplastics in peripheral blood are associated with COPD or IPF vs. no lung disease. In this pilot prospective case-control study, participants were grouped as control (n = 10), COPD (n = 9), or IPF (n = 10). Relevant comorbidities and exposures were obtained from records and questionnaires. All underwent standardized blood collection (PlasticTox©). Samples were analyzed for total microplastic concentration, stratified by size (p < 0.01). Particle burdens p < 0.01). After adjusting for smoking, only the <10 µm fraction remained independently associated with lung disease (adjusted odds ratio 1.94 (95% CI, 1.23–7.04)). In this pilot exploratory study, individuals with COPD or IPF showed greater circulating microplastic levels than controls. These findings should be interpreted as hypothesis-generating, and larger analytically validated studies are needed to clarify directionality, causal mechanisms, contamination control, and the clinical relevance of circulating microplastic burden.